Vaneck Biotech Etf Buy Hold or Sell Recommendation

BBH Etf  USD 151.99  1.02  0.67%   
Considering the 90-day investment horizon and your above-average risk tolerance, our recommendation regarding VanEck Biotech ETF is 'Strong Hold'. Macroaxis provides VanEck Biotech buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding BBH positions. The advice algorithm takes into account all of VanEck Biotech's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting VanEck Biotech's buy or sell advice are summarized below:
Real Value
154.07
Hype Value
151.99
Market Value
151.99
Naive Value
149.54
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell VanEck Biotech ETF given historical horizon and risk tolerance towards VanEck Biotech. When Macroaxis issues a 'buy' or 'sell' recommendation for VanEck Biotech ETF, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out VanEck Biotech Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
In addition, we conduct extensive research on individual funds such as VanEck and provide practical buy, sell, or hold recommendation based on investors' investing horizon and their risk tolerance towards VanEck Biotech ETF. Also, note that the market value of any etf could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.

Execute VanEck Biotech Buy or Sell Advice

The VanEck recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on VanEck Biotech ETF. Macroaxis does not own or have any residual interests in VanEck Biotech ETF or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute VanEck Biotech's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell VanEck BiotechBuy VanEck Biotech
Strong Hold

Market Performance

Very WeakDetails

Volatility

Very steadyDetails

Hype Condition

StaleDetails

Current Valuation

Fairly ValuedDetails

Odds Of Distress

LowDetails

Economic Sensitivity

Almost mirrors the marketDetails

Investor Sentiment

AlarmedDetails

Analyst Consensus

Not AvailableDetails
For the selected time horizon VanEck Biotech ETF has a Risk Adjusted Performance of (0.09), Jensen Alpha of (0.21), Total Risk Alpha of (0.24) and Treynor Ratio of (0.13)
Macroaxis provides recommendation on VanEck Biotech ETF to complement and cross-verify current analyst consensus on VanEck Biotech ETF. Our trade recommendation engine determines the etf's potential to grow exclusively from the perspective of an investor's current risk tolerance and investing horizon. Use VanEck Biotech total asset, five year return, as well as the relationship between the Five Year Return and last dividend paid to ensure your buy or sell decision on VanEck Biotech ETF is adequate.

VanEck Biotech Trading Alerts and Improvement Suggestions

VanEck Biotech ETF generated a negative expected return over the last 90 days
Latest headline from zacks.com: Should You Invest in the VanEck Biotech ETF
The fund generated three year return of -6.0%
VanEck Biotech ETF holds 99.96% of its assets under management (AUM) in equities

VanEck Biotech Returns Distribution Density

The distribution of VanEck Biotech's historical returns is an attempt to chart the uncertainty of VanEck Biotech's future price movements. The chart of the probability distribution of VanEck Biotech daily returns describes the distribution of returns around its average expected value. We use VanEck Biotech ETF price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of VanEck Biotech returns is essential to provide solid investment advice for VanEck Biotech.
Mean Return
-0.14
Value At Risk
-1.84
Potential Upside
1.24
Standard Deviation
0.96
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of VanEck Biotech historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

VanEck Biotech Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to VanEck Biotech or VanEck sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that VanEck Biotech's price will be affected by overall etf market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a VanEck etf's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over NYSE Composite
-0.21
β
Beta against NYSE Composite1.11
σ
Overall volatility
0.98
Ir
Information ratio -0.22

VanEck Biotech Volatility Alert

VanEck Biotech ETF exhibits very low volatility with skewness of -0.09 and kurtosis of -0.08. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure VanEck Biotech's etf risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact VanEck Biotech's etf price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.

VanEck Biotech Fundamentals Vs Peers

Comparing VanEck Biotech's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze VanEck Biotech's direct or indirect competition across all of the common fundamentals between VanEck Biotech and the related equities. This way, we can detect undervalued stocks with similar characteristics as VanEck Biotech or determine the etfs which would be an excellent addition to an existing portfolio. Peer analysis of VanEck Biotech's fundamental indicators could also be used in its relative valuation, which is a method of valuing VanEck Biotech by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare VanEck Biotech to competition
FundamentalsVanEck BiotechPeer Average
Price To Earning17.66 X3.15 X
Price To Book2.74 X0.39 X
Price To Sales4.72 X0.33 X
Beta0.85
One Year Return(7.10) %(0.97) %
Three Year Return(5.90) %3.23 %
Five Year Return5.10 %1.12 %
Ten Year Return6.30 %1.20 %
Net Asset478.42 M2.29 B
Last Dividend Paid0.470.14
Equity Positions Weight99.96 %52.82 %

VanEck Biotech Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as VanEck . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About VanEck Biotech Buy or Sell Advice

When is the right time to buy or sell VanEck Biotech ETF? Buying financial instruments such as VanEck Etf isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having VanEck Biotech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Utilities Thematic Idea Now

Utilities
Utilities Theme
Highly leveraged corporations that deliver utilities such as power, water or gas to public or business. The Utilities theme has 30 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Utilities Theme or any other thematic opportunities.
View All  Next Launch
When determining whether VanEck Biotech ETF offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of VanEck Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vaneck Biotech Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Vaneck Biotech Etf:
Check out VanEck Biotech Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
Note that the VanEck Biotech ETF information on this page should be used as a complementary analysis to other VanEck Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
The market value of VanEck Biotech ETF is measured differently than its book value, which is the value of VanEck that is recorded on the company's balance sheet. Investors also form their own opinion of VanEck Biotech's value that differs from its market value or its book value, called intrinsic value, which is VanEck Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VanEck Biotech's market value can be influenced by many factors that don't directly affect VanEck Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VanEck Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if VanEck Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VanEck Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.